BIOHAVEN PHARMACTL HLDG CO L BHVN
COM · Common Stock · CUSIP G11196105 · ISIN VGG111961055
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNew Haven, CT
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $24.04.
Trends to Q1 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 240 |
| Q4 2022 | 7 |
| Q1 2023 | 2 |
| Q2 2023 | 1 |
| Q3 2023 | 1 |
| Q4 2023 | 2 |
| Q1 2024 | 2 |
| Q2 2024 | 3 |
| Q3 2024 | 3 |
| Q4 2024 | 2 |
| Q1 2025 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2023 | 0 | 1 |
| Q3 2023 | 1 | 0 |
| Q4 2023 | 1 | 0 |
| Q1 2024 | 0 | 0 |
| Q2 2024 | 2 | 0 |
| Q3 2024 | 1 | 1 |
| Q4 2024 | 1 | 1 |
| Q1 2025 | 2 | 1 |
Biggest buyers
| Knoll Capital Management, LLC | Added | +70.5k |
| FNY Investment Advisers, LLC | New | +800 |
Biggest sellers
| Birchview Capital, LP | Sold out | -14.7k |
Insider purchases and sales in Q1 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 1 | $2.9m | 0 | — | — |
| Q4 2023 | 4 | $20.9m | 1 | $459.7k | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 4 | $14.5m | 0 | — | — |
| Q3 2024 | 2 | $1.2m | 0 | — | — |
| Q4 2024 | 2 | $2.0m | 0 | — | — |
| Q1 2025 | 1 | $864.2k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-03-04 | CHILDS JOHN W Director · By John W Childs 2013 Revocable Trust | Bought | $864.2k28.4k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q1 2025
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLC 12.99% of their portfolio | 830.9k $20.0m | Added +70.5k |
| FNY Investment Advisers, LLC 0.01% of their portfolio | 800 $19.0k | New |